For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Beam Therapeutics Inc (NASDAQ: BEAM) closed at $23.30 in the last session, up 1.88% from day before closing price of $22.87. In other words, the price has increased by $1.88 from its previous closing price. On the day, 2.51 million shares were traded. BEAM stock price reached its highest trading level at $23.43 during the session, while it also had its lowest trading level at $22.14.
Ratios:
We take a closer look at BEAM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.82 and its Current Ratio is at 4.82. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.20.
Leerink Partners Upgraded its Market Perform to Outperform on November 06, 2024, whereas the target price for the stock was revised from $27 to $39.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 18 ’25 when Cavanagh Bethany J sold 6,287 shares for $35.00 per share. The transaction valued at 220,045 led to the insider holds 37,527 shares of the business.
Bellon Christine sold 10,000 shares of BEAM for $340,000 on Feb 14 ’25. The Chief Legal Officer now owns 102,968 shares after completing the transaction at $34.00 per share. On Feb 14 ’25, another insider, CHRISTINE BELLON, who serves as the Officer of the company, bought 10,000 shares for $34.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BEAM now has a Market Capitalization of 2326272000 and an Enterprise Value of 1200581504. For the stock, the TTM Price-to-Sale (P/S) ratio is 36.62 while its Price-to-Book (P/B) ratio in mrq is 2.66. Its current Enterprise Value per Revenue stands at 18.901 whereas that against EBITDA is -3.05.
Stock Price History:
The Beta on a monthly basis for BEAM is 1.96, which has changed by -0.3084001 over the last 52 weeks, in comparison to a change of 0.086116076 over the same period for the S&P500. Over the past 52 weeks, BEAM has reached a high of $36.75, while it has fallen to a 52-week low of $20.84. The 50-Day Moving Average of the stock is -12.75%, while the 200-Day Moving Average is calculated to be -9.72%.
Shares Statistics:
According to the various share statistics, BEAM traded on average about 1.52M shares per day over the past 3-months and 2987050 shares per day over the past 10 days. A total of 99.84M shares are outstanding, with a floating share count of 88.04M. Insiders hold about 11.82% of the company’s shares, while institutions hold 69.86% stake in the company. Shares short for BEAM as of 1740700800 were 9992985 with a Short Ratio of 6.56, compared to 1738281600 on 10015050. Therefore, it implies a Short% of Shares Outstanding of 9992985 and a Short% of Float of 15.57.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
